Tiziana Life Sciences to present Phase 2a BANYAN poster
Tiziana Life Sciences (TLSA) announces a poster presentation at ALS Nexus 2026 covering its Phase 2a BANYAN clinical trial of intranasal foralumab.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Tiziana Life Sciences (TLSA) announces a poster presentation at ALS Nexus 2026 covering its Phase 2a BANYAN clinical trial of intranasal foralumab.